SKYE News and Press, Skye Bioscience Inc Com From 09/07/21

SAN DIEGO, CA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, announced today that it will be presen...

The following slide deck was published by Skye Bioscience, Inc. in conjunction with this event. For further details see: Skye Bioscience (SKYE) Corporate Presentation - Slideshow

SAN DIEGO, CA, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, announced today that Karam Takhar, VP of Co...

THCVHS shows no signs of chromosomal or gene mutations in preclinical studies SAN DIEGO, CA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat...

OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing Canada NewsWire Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , Aug. 9, ...

Executive Presentations at Live Virtual Small Cap Growth Investor Conference: Thursday August 5th Canada NewsWire Company executives will share vision and answer audience questions at VirtualInvestorConferences.com NEW YORK , Aug. 3, 2021 /CNW/ - Vir...

Live Investor Conference & Webinar: OTCQB Venture Conference on August 5th Live Investor Conference & Webinar: OTCQB Venture Conference on August 5th Company executives will share vision and answer audience questions at VirtualInvestorConferences.com PR Newswire ...

SAN DIEGO, CA, July 26, 2021 (GLOBE NEWSWIRE) --  Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant...

Cannabis Industry Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations PR Newswire NEW YORK , July 1, 2021 /PRNe...

Cannabis Industry Investor Conference: Company Executives Present June 29th & 30th Cannabis Industry Investor Conference: Company Executives Present June 29th & 30th Canada NewsWire Cannabis Company Executives share vision, answer questions live at Virtua...